Literature DB >> 21686662

Cerebral haemorrhage as the presenting feature of myeloproliferative disorder.

Jyothi Kondlapudi1, Rory J O'Connor, Samantha Mawer.   

Abstract

Myeloproliferative disorders predispose individuals to bleeding and thrombosis, often with devastating consequences. We report a 41-year-old man who presented with headache, amnesia and dysphagia due to cerebral haemorrhage. Extensive investigation revealed the cause of the neurological syndrome as an underlying essential thrombocytosis. The patient made a full recovery following extensive inpatient and community rehabilitation, returning to work after 6 months. We discuss the diagnosis and management of stroke due to myeloproliferative conditions. This case report illustrates the importance of multidisciplinary teamwork in fully investigating and treating all patients with acute onset of stroke.

Entities:  

Year:  2009        PMID: 21686662      PMCID: PMC3029860          DOI: 10.1136/bcr.08.2008.0720

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  15 in total

1.  Cerebral embolism in a patient with polycythemia rubra vera.

Authors:  T Segura; J Serena; J Teruel; A Dávalos
Journal:  Eur J Neurol       Date:  2000-01       Impact factor: 6.089

2.  Watershed infarction in a case of polycythemia vera.

Authors:  R Yazdi; C Côté
Journal:  Clin Nucl Med       Date:  1986-09       Impact factor: 7.794

3.  Collaborative systematic review of the randomised trials of organised inpatient (stroke unit) care after stroke. Stroke Unit Trialists' Collaboration.

Authors: 
Journal:  BMJ       Date:  1997-04-19

4.  Maternal death from carotid artery thrombosis associated with the syndrome of hemolysis, elevated liver function, and low platelets.

Authors:  V L Katz; R C Cefalo
Journal:  Am J Perinatol       Date:  1989-07       Impact factor: 1.862

5.  Early supported discharge services for stroke patients: a meta-analysis of individual patients' data.

Authors:  Peter Langhorne; Gillian Taylor; Gordon Murray; Martin Dennis; Craig Anderson; Erik Bautz-Holter; Paola Dey; Bent Indredavik; Nancy Mayo; Michael Power; Helen Rodgers; Ole Morten Ronning; Anthony Rudd; Nijasri Suwanwela; Lotta Widen-Holmqvist; Charles Wolfe
Journal:  Lancet       Date:  2005 Feb 5-11       Impact factor: 79.321

6.  Thrombotic and hemorrhagic complications in chronic myeloproliferative disorders.

Authors:  A Sagripanti; A Ferretti; A Nicolini; A Carpi
Journal:  Biomed Pharmacother       Date:  1996       Impact factor: 6.529

7.  Progressive occlusive disease of large cerebral arteries and ischemic events in a patient with essential thrombocythemia.

Authors:  Maria Mosso; Dimitrios Georgiadis; Ralf W Baumgartner
Journal:  Neurol Res       Date:  2004-09       Impact factor: 2.448

8.  Essential thrombocytemia and ischemic stroke: report of six cases.

Authors:  L Casto; M Camerlingo; G Finazzi; B Censori; T Barbui; A Mamoli
Journal:  Ital J Neurol Sci       Date:  1994-10

9.  Polycythemia vera: the natural history of 1213 patients followed for 20 years. Gruppo Italiano Studio Policitemia.

Authors: 
Journal:  Ann Intern Med       Date:  1995-11-01       Impact factor: 25.391

10.  Efficacy and safety of low-dose aspirin in polycythemia vera.

Authors:  Raffaele Landolfi; Roberto Marchioli; Jack Kutti; Heinz Gisslinger; Gianni Tognoni; Carlo Patrono; Tiziano Barbui
Journal:  N Engl J Med       Date:  2004-01-08       Impact factor: 91.245

View more
  2 in total

1.  Essential thrombocythemia with CALR mutation and recurrent stroke: two case reports and literature review.

Authors:  Rong Chen; Xiaodan Shi; Luojun Wang; Xuan Wang; Jingya Wei; Xiaogang Kang; Fang Du; Shan Gao; Fang Yang; Wen Jiang
Journal:  Ther Adv Neurol Disord       Date:  2022-04-26       Impact factor: 6.430

2.  Complex intracranial vascular complications caused by essential thrombocythemia: a critical case report.

Authors:  Jian Xie; Leiyu Geng; Baoyu Yuan; Yijing Guo; Zhijun Zhang
Journal:  BMC Neurol       Date:  2020-11-07       Impact factor: 2.474

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.